Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes-The RESTORE-G Real-World Study

被引：0
|
作者：
Candido, Riccardo
Nicolucci, Antonio
Larosa, Monica
Rossi, Maria Chiara
Napoli, Raffaele
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-87-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
    Weiss, Tracey
    Yang, Lingfeng
    Carr, Richard D.
    Pal, Sampriti
    Sawhney, Baanie
    Boggs, Robert
    Rajpathak, Swapnil
    Iglay, Kristy
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (01)
  • [32] The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
    Win L. Yin
    Steve C. Bain
    Thinzar Min
    Diabetes Therapy, 2020, 11 : 835 - 844
  • [33] Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
    Katherine A. Lyseng-Williamson
    Clinical Drug Investigation, 2019, 39 : 805 - 819
  • [34] COPD Exacerbations in Patients With Type 2 Diabetes on Glucagon-like Peptide-1 Receptor Agonists
    Foer, D.
    Strasser, Z. H.
    Cui, J.
    Cahill, K. N.
    Murphy, S. N.
    Karlson, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [35] Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
    Ahren, Bo
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 196 - 201
  • [36] Glucagon-like Peptide-1 Receptor Agonists Prescribing Patterns in Youth with Type 2 Diabetes
    Bensignor, Megan
    Kelly, Aaron
    Wolfe, Jack
    Rudser, Kyle
    Arslanian, Silva
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 81 - 82
  • [37] Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
    Watchorn, David
    O'Shea, Donal
    Butler, Marcus W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) : 923 - 924
  • [38] Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
    Lovshin, Julie A.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 524 - 535
  • [39] Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
    Mosenzon, Ofri
    Schechter, Meir
    Leibowitz, Gil
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 347 - 360
  • [40] The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
    Yin, Win L.
    Bain, Steve C.
    Min, Thinzar
    DIABETES THERAPY, 2020, 11 (04) : 835 - 844
12345